THE TEAM
Experience. Expertise. Shared purpose.
An experienced founding team and complementary advisors, united by a commitment to new medicines and patient impact.
The founders
Mark
CEO, CO-FOUNDER
Former Director of Biophysics at AstraZeneca. Led platform development and discovery programmes; contributor to five drug candidates. Co-founder of Domainex. Focus: strategy, partnerships and value creation.
Michal
CSO, CO-FOUNDER
Former VP Structure, Biophysics and Fragments at Captor Therapeutics. Previously a senior scientist at AstraZeneca and contributor to three drug candidates. Experience at MRC-LMB, UK. Focus: research, innovation and pipeline development.
The advisors
Prof Mike Waring
CHEMISTRY ADVISOR
30+ years in medicinal chemistry. Professor of Medicinal Chemistry at Newcastle University; contributor to 14 drug candidates, including Tagrisso®.
Prof Marcin Cieslik
BIOINFORMATICS & CANCER BIOSCIENCE
13 years in cancer genomics, computational biology and bioinformatics. Professor at the University of Michigan Medical School.
Dr Iain Comley
BUSINESS DEVELOPMENT ADVISOR
25+ years in pharma and biotech business development. Former Head of Transactions at AstraZeneca.